Please assess the completion status of the following clinical trial:

Trial Title: Acute Versus Subacute Angioplasty in Patients With NON-ST-Elevation Myocardial Infarction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Angina~* Elevated biomarkers (Point-of-care testing) either prehospital or immediately on admission~* ST-segment depression of 0.2mV or more in two contiguous leads or 0.1 mV or more in four contiguous leads.~* Patient can be randomized either in the prehospital phase or within 30 minutes of admission to a hospital~Exclusion Criteria:~* Tachycardia \> 120~* Age \< 18 or \> 80 years~* Indication for PPCI already fulfilled~* Dementia~* Patient cannot understand the study information~* Presumed troponisme~* Left ventricular hypertrophy~* Known dialysis~* Previous CABG~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Group I: PPCI (Type: EXPERIMENTAL): Patients are treated with Aspirin, ADP-blocker and heparin and field-triaged or transferred immediately to an invasive center for PPCI
- Conventional: Group II (Type: NO_INTERVENTION): Patients are treated as today: Admission to local hospital, Low-molecular-weight heparin (LMWH), Aspirin, ADP-blocker and within 72 hours transfer for angiography/angioplasty. Patients with a Grace score \> 140 will be transferred for angiography/angioplasty within 24 hours. Patients with refractory angina, severe heart failure, life-threatening ventricular arrhythmias or haemodynamic instability will be transferred acutely for angiography/angioplasty according to the european guidelines.

Based on this trial design, predict the completion outcome and termination type (if applicable).